Message Font: Serif | Sans-Serif
No. of Recommendations: 4
BOSTON (CBS.MW) -- Boston Scientific's highly anticipated new cardiovascular stent dramatically reduced the rate of vessel reblockage among heart disease patients who received the device in late-stage clinical testing, the company said Monday.

By one measure, patients who received the "drug-coated" stent had reclosure rates of 7.9 percent compared with 26.6 percent for patients who got older "bare" stents,

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.